Introduction: Metabolic and bariatric surgery (MBS) is associated with various postoperative complications and extended hospital stays. Standardized management protocols may enhance patient outcomes.

A head-to-head comparison of the JAK inhibitor drug tofacitinib and chimeric monoclonal antibody infliximab in the treatment of acute severe ulcerative colitis (ASUC) shows that, contrary to concerns, ...

Phase II study of the safety and efficacy of discontinuing pegfilgrastim for pancreatic adenocarcinoma treated with FOLFIRINOX. This is an ASCO Meeting Abstract from the 2024 ASCO Gastrointestinal ...

Camrelizumab combined with apatinib as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A phase 2 trial. Interim results from a prospective multicenter phase II trial of ...